Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosa.
Garey
K W
KW
Department of Clinical Science and Administration, University of Houston College of Pharmacy, Houston, TX 77030, USA. kgarey@uh.edu
Martorell
M V
MV
Vo
Q P
QP
Tam
V H
VH
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D055499:Catheter-Related Infections / Q000188:drug therapy; D002448:Cell Adhesion; D004359:Drug Therapy, Combination; D006801:Humans; D008826:Microbial Sensitivity Tests; D010878:Piperacillin / Q000008:administration & dosage*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012293:Rifampin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D012293:Rifampin; D010878:Piperacillin